Julian and Sebastian Reitbauer are building Moodsup, an Austrian consumer health brand focused on sleep and evening routines. Their first product, the sleep supplement Night Shield, is scheduled to launch on December 17th.
Vienna-based startup Primedea has closed a six-figure pre-seed funding round. The round was led by the Hansmann Family Office, backed by business angel Hansi Hansmann. Primedea will use the capital to expand its teleradiology network and invest in its own AI applications for radiology. The platform connects hospitals and radiology centers with certified specialists; AI assists with referrals and reporting, while medical decisions remain with the physicians.
The HUF 15 billion Life Sciences Catalyst Program will support healthcare SMEs developing medical devices and Phase I drug development from January 5, 2027. Applicants can seek non-repayable grants of HUF 300 million to HUF 3 billion.
Dr. István Peták's development won the top prize in the healthcare category of the Blue Earth Summit BE100 innovation competition in London. Genomate Health's technology, developed by Hungarian researchers, mathematically analyzes the genetic variations of a tumor, drugs and scientific evidence to rank potential targeted therapies. The article discusses the company's previous international recognitions, its merger with Oncompass Medicine, and the fact that the solution is currently available in private care in Hungary.
After a challenging year in sourcing raw materials, the Styrian startup BerBerSan is launching a second product in Austrian pharmacies. With Suxero, the founding team is expanding its portfolio and targeting international expansion in addition to the domestic market.
Raiffeisenlandesbank Niederösterreich-Wien is taking a 10 percent stake in Lumetry Diagnostics as lead investor; the investment amount was not disclosed. The capital will help the Graz-based MedTech company launch the first CE-marked product version of its breath-analysis device for COPD patients in Europe. The device combines spirometry and capnography; AI-powered algorithms for a follow-up model are undergoing clinical trials.